Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion

Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion

The big biotech wants to bolster its late-stage pipeline with a potential new stomach cancer treatment.